Coronavirus: Dealing with Delta variant with COVID-19 vaccination

The delta variant is the fourth variant of concern identified by the World Health Organization (WHO), first identified in India (April 2021) and it’s quickly becoming the dominant variant across the world. It has now overwhelmed the medical ecosystem globally. Since then it has made its way to many countries in South East Asia, Europe, UK and now is also a dominant mutant in the USA and Canada.

As per researches, the Delta variant is the most transmissible form of the virus and mostly deadlier too. What makes Delta variant different and more dangerous from the other mutations is that it has many spike proteins that enable it to bind to our body cells more rapidly and efficiently. As per research, the most pronounced reduction was observed for the B.1.351 (Beta; 3.6-fold) and P.1 (Gamma; 3.4-fold) variants that contain similar mutations in the receptor-binding domain (RBD) while only a 1.6-fold reduction was observed for the widely spreading B.1.617.2 (Delta) variant. This simply means that people infected with this mutation tend to transmit more of this virus around, and as a result of which it affects about 60 per cent plus efficiently more than previous variants. Factually, all the coronavirus variants share many similarities, however, recent findings show that the delta variant causes more headache to start with, along with sore throat, runny nose, and fever. It was striking to notice that the traditional early symptoms of Covid 19 were observed lesser in this new…